Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ SPARC AI Inc. Announces Closing of First Tranche of Brokered LIFE Financing for $4.34 Million from an... (GlobeNewswire EN) +++ SPARC AI Aktie +3,82%

News zum Sektor Gesundheit aus Belgien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1550 Aktien zum Sektor Gesundheit bekannt.
 
03.06.26 - 18:00
OXURION : Oxurion Announces Results on the Annual Shareholders′ Meeting of 1 June 2026 (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
03.06.26 - 17:42
Agfa-Gevaert announces changes to the Board of Directors (GlobeNewswire EN)
 
June 3, 2026 – 5.40 PM CET Regulated information...
02.06.26 - 18:00
OXURION : Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
01.06.26 - 21:03
IBA – ACQUISITION OF OWN SHARES (GlobeNewswire EN)
 
Louvain-la-Neuve, Belgium, June 1st, 2026 – 9 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....
01.06.26 - 17:15
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members (PR Newswire)
 
Applications open June 1 for UCB's Hidradenitis Suppurativa Scholarship™ Program Informed by patient insights, the initiative builds on UCB's network of scholarship programs in myasthenia gravis and epilepsy ATLANTA, June 1, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company,......
01.06.26 - 07:33
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (GlobeNewswire EN)
 
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced that The Lancet, a world-leading medical journal, has published the full results from the Phase 3 PHOENYCS GO clinical trial evaluating dapirolizumab pegol (DZP), an investigational, novel Fc-free CD40L inhibitor, in patients living with moderate-to-severe active systemic lupus erythematosus (SLE). The results showed statistically significant improvement in disease activity with DZP added to standard of care (SOC) versus placebo plus standard of care.1...
01.06.26 - 07:30
Biogen, UCB lupus drug dapirolizumab pegol meets phase 3 goal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.06.26 - 07:03
IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production (GlobeNewswire EN)
 
Louvain-la-Neuve, Belgium – 01 June 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today launches Cyclone® iKure, a dedicated cyclotron for routine Astatine-211 (At-211) production. Designed for alpha-beam irradiation, this new cyclotron enables radiopharmaceutical manufacturers, research institutions and healthcare providers to accelerate access to targeted alpha therapies with the reliability and quality required for clinical-scale programs....
29.05.26 - 18:00
OXURION : Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
27.05.26 - 18:00
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
26.05.26 - 18:03
IBA – ACQUISITION OF OWN SHARES (GlobeNewswire EN)
 
Louvain-la-Neuve, Belgium, May 26th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....
26.05.26 - 18:01
OXURION : Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
22.05.26 - 10:27
Pharma: Investoren bieten Milliardenbetrag für Pharmafirma Recordati (Handelsblatt)
 
Die Finanzinvestoren CVC Capital Partners und Groupe Bruxelles Lambert legen ein Milliardenangebot für den Pharmakonzern vor. Gleichzeitig planen sie dessen Rückzug von der Börse....
22.05.26 - 08:42
CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private (WSJ EN)
 
The consortium said the offer is aimed at delisting Recordati from Euronext Milan and supporting the drugmaker's expansion in rare diseases....
22.05.26 - 08:36
CVC, GBL Offer to Acquire Italy′s Recordati in $12 Billion Deal (Bloomberg)
 
CVC Capital Partners Plc and Groupe Bruxelles Lambert offered to buy Recordati SpA in a deal valuing the Italian drugmaker at more than $12 billion, which would be one of the biggest healthcare deals in Europe this year....
21.05.26 - 07:03
First quarter 2026 update: starting the year on track, with product innovation progress (GlobeNewswire EN)
 
Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026....
20.05.26 - 22:09
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum (GlobeNewswire EN)
 
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum...
20.05.26 - 17:42
Agfa-Gevaert announces resignation of Michel Govaert from the Board of Directors (GlobeNewswire EN)
 
                                       ...
20.05.26 - 12:18
MDxHealth: Aktie stürzt nach verfehlten Q1-Prognosen ab (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn in Salzburg nicht endlich ein wirklich geistiger Prozess eingeleitet wird, ist das Festival am Ende. - Dr. Gérard Mortier
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!